C/EBP beta LIP augments cell death by inducing osteoglycin

Research output: Contribution to journalArticlepeer-review


Many types of tumor cell are devoid of the extracellular matrix proteoglycan osteoglycin (Ogn), but its role in tumor biology is poorly studied. Here we show that RNAi of Ogn attenuates stress-triggered cell death, whereas its overexpression increases cell death. We found that the transcription factor C/EBP beta regulates the expression of Ogn. C/EBP beta is expressed as a full-length, active form (LAP) and as a truncated, dominant-negative form (LIP), and the LIP/LAP ratio is positively correlated with the extent of cell death under stress. For example, we reported that drug-resistant tumor cells lack LIP altogether, and its supplementation abolished their resistance to chemotherapy and to endoplasmic reticulum (ER) stress. Here we further show that elevated LIP/LAP ratio robustly increased Ogn expression and cell death under stress by modulating the mitogen-activated protein kinase/activator protein 1 pathway (MAPK/AP-1). Our findings suggest that LIP deficiency renders tumor cell resistant to ER stress by preventing the induction of Ogn.
Original languageEnglish
Article number2733
Number of pages10
JournalCell Death & Disease
StatePublished - Apr 2017


Dive into the research topics of 'C/EBP beta LIP augments cell death by inducing osteoglycin'. Together they form a unique fingerprint.

Cite this